Novel gene therapy platform delivering non-viral treatments to mucosal tissues and organs.
Location: Canada, Montreal (06), Montreal
Investors 1
| Date | Name | Website |
| 10.03.2024 | Omega Fund... | omegafunds... |
Mentions in press and media 9
| Date | Title | Description | Source |
| 02.11.2023 | Lumira Ventures Portfolio Company enGene (Nasdaq: ENGN) Debu... | CAD$191 million gross proceeds from the transaction to support the advancement of the clinical progr... | lumiravent... |
| 27.05.2021 | Lumira Portfolio Company, enGene, Announces First-in-Human D... | BOSTON and MONTRÉAL, May 27, 2021: enGene Inc., a clinical-stage biotechnology company developing no... | lumiravent... |
| 27.05.2021 | enGene Announces First-in-Human Dosing of EG-70 for the Trea... | prnewswire... | |
| 03.12.2020 | enGene Receives Fast Track Designation for EG-70 for the Tre... | prnewswire... | |
| 02.11.2020 | enGene Announces FDA Clearance of IND Application for EG-70,... | prnewswire... | |
| 29.10.2020 | enGene Receives Funding Through Cystic Fibrosis Foundation's... | prnewswire... | |
| 09.01.2020 | enGene Expands Senior Management Team | BOSTON and MONTRÉAL /PRNewswire/ – enGene Inc., the biotechnology company developing rationally desi... | lumiravent... |
| 29.05.2019 | enGene Appoints José M. Lora, Ph.D. as Chief Scientific Offi... | MONTRÉAL and BOSTON, May 29, 2019 — enGene Inc., the high growth biotechnology company developing th... | lumiravent... |
| - | enGene | “Discover the future of genetic medicine. enGene is developing locally administered, non-viral gene ... | fastfounde... |